MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression
Increased mitochondrial function may render some cancers vulnerable to mitochondrial inhibitors. Since mitochondrial function is regulated partly by mitochondrial DNA copy number (mtDNAcn), accurate measurements of mtDNAcn could help reveal which cancers are driven by increased mitochondrial function and may be candidates for mitochondrial inhibition. However, prior studies have employed bulk macrodissections that fail to account for cell type-specific or tumor cell heterogeneity in mtDNAcn. These studies have often produced unclear results, particularly in prostate cancer. Herein, we developed a multiplex in situ method to spatially quantify cell type-specific mtDNAcn. We show that mtDNAcn is increased in luminal cells of high-grade prostatic intraepithelial neoplasia (HGPIN), is increased in prostatic adenocarcinomas (PCa), and is further elevated in metastatic castration-resistant prostate cancer. Increased PCa mtDNAcn was validated by 2 orthogonal methods and is accompanied by increases in mtRNAs and enzymatic activity. Mechanistically, MYC inhibition in prostate cancer cells decreases mtDNA replication and expression of several mtDNA replication genes, and MYC activation in the mouse prostate leads to increased mtDNA levels in the neoplastic prostate cells. Our in situ approach also revealed elevated mtDNAcn in precancerous lesions of the pancreas and colon/rectum, demonstrating generalization across cancer types using clinical tissue samples.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
JCI insight - 8(2023), 24 vom: 22. Dez. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Jiayu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer |
|---|
| Anmerkungen: |
Date Completed 03.01.2024 Date Revised 16.03.2024 published: Electronic UpdateOf: bioRxiv. 2023 Mar 10;:. - PMID 36865273 Citation Status MEDLINE |
|---|
| doi: |
10.1172/jci.insight.169868 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364634510 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364634510 | ||
| 003 | DE-627 | ||
| 005 | 20240316232607.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1172/jci.insight.169868 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1332.xml |
| 035 | |a (DE-627)NLM364634510 | ||
| 035 | |a (NLM)37971875 | ||
| 035 | |a (PII)e169868 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Jiayu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.01.2024 | ||
| 500 | |a Date Revised 16.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a UpdateOf: bioRxiv. 2023 Mar 10;:. - PMID 36865273 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Increased mitochondrial function may render some cancers vulnerable to mitochondrial inhibitors. Since mitochondrial function is regulated partly by mitochondrial DNA copy number (mtDNAcn), accurate measurements of mtDNAcn could help reveal which cancers are driven by increased mitochondrial function and may be candidates for mitochondrial inhibition. However, prior studies have employed bulk macrodissections that fail to account for cell type-specific or tumor cell heterogeneity in mtDNAcn. These studies have often produced unclear results, particularly in prostate cancer. Herein, we developed a multiplex in situ method to spatially quantify cell type-specific mtDNAcn. We show that mtDNAcn is increased in luminal cells of high-grade prostatic intraepithelial neoplasia (HGPIN), is increased in prostatic adenocarcinomas (PCa), and is further elevated in metastatic castration-resistant prostate cancer. Increased PCa mtDNAcn was validated by 2 orthogonal methods and is accompanied by increases in mtRNAs and enzymatic activity. Mechanistically, MYC inhibition in prostate cancer cells decreases mtDNA replication and expression of several mtDNA replication genes, and MYC activation in the mouse prostate leads to increased mtDNA levels in the neoplastic prostate cells. Our in situ approach also revealed elevated mtDNAcn in precancerous lesions of the pancreas and colon/rectum, demonstrating generalization across cancer types using clinical tissue samples | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Metabolism | |
| 650 | 4 | |a Mitochondria | |
| 650 | 4 | |a Oncology | |
| 650 | 7 | |a DNA, Mitochondrial |2 NLM | |
| 650 | 7 | |a Myc protein, mouse |2 NLM | |
| 700 | 1 | |a Zheng, Qizhi |e verfasserin |4 aut | |
| 700 | 1 | |a Hicks, Jessica L |e verfasserin |4 aut | |
| 700 | 1 | |a Trabzonlu, Levent |e verfasserin |4 aut | |
| 700 | 1 | |a Ozbek, Busra |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, Tracy |e verfasserin |4 aut | |
| 700 | 1 | |a Vaghasia, Ajay M |e verfasserin |4 aut | |
| 700 | 1 | |a Larman, Tatianna C |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Rulin |e verfasserin |4 aut | |
| 700 | 1 | |a Markowski, Mark C |e verfasserin |4 aut | |
| 700 | 1 | |a Denmeade, Sam R |e verfasserin |4 aut | |
| 700 | 1 | |a Pienta, Kenneth J |e verfasserin |4 aut | |
| 700 | 1 | |a Hruban, Ralph H |e verfasserin |4 aut | |
| 700 | 1 | |a Antonarakis, Emmanuel S |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Anuj |e verfasserin |4 aut | |
| 700 | 1 | |a Dang, Chi V |e verfasserin |4 aut | |
| 700 | 1 | |a Yegnasubramanian, Srinivasan |e verfasserin |4 aut | |
| 700 | 1 | |a De Marzo, Angelo M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JCI insight |d 2016 |g 8(2023), 24 vom: 22. Dez. |w (DE-627)NLM257703918 |x 2379-3708 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2023 |g number:24 |g day:22 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1172/jci.insight.169868 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2023 |e 24 |b 22 |c 12 | ||